My GSK Singapore story Asyraf: Senior Operations Technician 1:11 My GSK Singapore story Daniel: Data Scientist 1:38 My GSK Singapore story Nivi: Vaccines Market Leader, Greater China and Intercontinental 1:23 My GSK Singapore story Juli: Commercial Operations Manager - Emerging Markets Specialty ...
[1] GSK’s Regional President Mike Crichton on leading winning teams from Singapore. Retrieved April 26, 2023, from https://www.edb.gov.sg/en/business-insights/insights/gsk-s-regional-president-mike-crichton-on-leading-winning-teams-from-singapore.html...
Asia Dow4,370.47-7.26-0.17% Nikkei 22539,605.80224.910.57% Hang Seng21,251.98614.742.98% Shanghai3,217.74-84.19-2.55% Sensex81,381.36-230.05-0.28% Singapore3,573.76-11.53-0.32% Latest NewsAll Times Eastern scroll upscroll down 2:00pBarron'sGoldman Sachs, Netflix, United Airlines, TSMC, and...
Health-related Investigation Fellowship (NLG), an Australian Investigation Council Future Fellowship (SG Post author gsk-3 inhibitorPost read time2 min read Health-related Research Fellowship (NLG), an Australian Investigation Council Future Fellowship (SG), an NHMRC Biomedical... Post Categories Un...
Global leader in consumer health set to be a newly independent company with focused strategy to deliver sustainable above-market growth and attractive returns to shareholders Demerger and listing of Haleon expected in July 2022 New company to focus 100% on consumer health, with clear purpose to ...
Radiotherapy is one of the most common and effective treatment methods for cancer, and improving the radiosensitivity of tumor tissues during the treatment process is vital. We report the mechanisms of glycogen synthase kinase 3 (GSK-3) β-regulated auto
GSK650394是一种新颖的SGK抑制剂,在SPA实验中,对SGK1和SGK2的IC50分别为62nM和103nM。 注:本品仅可用于科研实验,严禁用于临床医疗及其他用途! CAS号:890842-28-1 纯度:99.38% 分子式:C??H??N?O? 分子量:382.45 结构式: 储存条件:-20℃,有效期2年,溶入溶剂后-20℃请尽量在一个月内使用。
Dann SG, Ryskin M, Barsotti AM, Golas J, Shi C, Miranda M, et al. Reciprocal regulation of amino acid import and epigenetic state through Lat1 and EZH2. EMBO J. 2015;34(13):1773–85. Article PubMed PubMed Central CAS Google Scholar Dahlem C, Abuhaliema A, Kessler SM, Kröhl...
GSK650394是一种新颖的SGK抑制剂,在SPA实验中,对SGK1和SGK2的IC50分别为62nM和103nM。 注:本品仅可用于科研实验,严禁用于临床医疗及其他用途! CAS号:890842-28-1 纯度:99.38% 分子量:382.45 储存条件:-20℃,有效期2年,溶入溶剂后-20℃请尽量在一个月内使用。